Patric C. Klotzbuecher

FDA investigator · also recorded as Patrie C. Klotzbuecher, Patrick C. Klotzbuecher

Appears on 13 documents from 2014 to 2019, most often at sites in India. Most often cites general requirements (21 CFR 211.160).

13
Documents on file
4.5
Observations per 483
2014
First seen
2019
Most recent

What they cite most

From 58 observations

Activity by year

2014: 1, 2016: 4, 2017: 1, 2018: 1, 2019: 6

Where

India 6 · New York 2 · Germany 1 · Illinois 1 · Japan 1 · Netherlands 1

Is Patric C. Klotzbuecher coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Regeneron Pharmaceuticals IncOct 18, 2019 · Rensselaer, New York
483 Takeda Pharmaceutical Company LimitedAug 9, 2019 · Yodogawa-Ku, Japan
483 NATCO PHARMA LIMITEDJun 6, 2019 · Kothur, India
483 Intas Pharmaceuticals LimitedMay 28, 2019 · Ahmedabad, India
483 KVK-Tech, IncApr 16, 2019 · Newtown, Pennsylvania
483 Rottendorf Pharma GmbHFeb 21, 2019 · Ennigerloh, Germany
483 Cipla LimitedApr 13, 2018 · Pithampur, India

About this profile

What does Patric C. Klotzbuecher inspect?

Patric C. Klotzbuecher appears on 13 documents on file covering 13 sites, most often in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.192 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Patric C. Klotzbuecher is dated Oct 18, 2019.